What is the role of dysregulated transforming growth factor beta (TGFB) signaling in the development of sex cordstromal tumors in the testis?
Introduction
Transforming growth factor beta (TGFB) superfamily members, which are structurally related proteins, regulate a broad range of cellular properties, including, but not limited to growth, differentiation, migration and apoptosis (Massague, 1998; Massague et al., 2000) . Because of their fundamental roles in these cellular events, TGFB superfamily members exhibit diverse physiological and pathological functions in multiple organ systems. In the reproductive system, recent studies, particularly those using genetics and functional genomics approaches uncovered many previously unrecognized roles of this growth factor family in reproductive development and cancer (Massague et al., 2000; Padua and Massague, 2009; Li, 2014; Fang et al., 2016) . TGFB signaling is known to be a double-edged sword in tumor development, exhibiting tumorigenic or tumor suppressive effects at different tumor stages (Massague, 2008) . To initiate signal transduction, TGFB ligands recruit type II and type I receptor complexes and activate canonical and/or non-canonical pathways depending on the signaling context (Akhurst and Hata, 2012) . In general, TGFB ligands signal through TGFBR1/ TGFBR2-SMAD2/3 axis, whereas bone morphogenetic proteins (BMPs) activate BMP type II and type I receptors and the SMAD1/5/9 signaling branch. SMAD4 is a common SMAD utilized by both TGFB and BMP signaling to access gene regulatory apparatus within the nuclear compartment (Fang et al., 2016) .
Approximately 95% of malignant testicular tumors belong to germ cell tumors, comprising seminomas and nonseminomas (Motzer et al., 2012) . Sex cord-stromal tumors (3-5%) of the testis include Leydig cell tumor, Sertoli cell tumor, granulosa cell tumor (GrCT), mixed sex cord-stromal tumor and unclassified sex cord-stromal tumor (Moch et al., 2016) . Testicular GrCTs are rare tumors (Mohapatra et al., 2016) . The formation of testicular GrCTs has been reported in several mouse models (Matzuk et al., 1992; Boyer et al., 2009; Richards et al., 2012) . The pathogenesis of GrCTs is poorly understood in both genders, due in part to the limited access to human GrCT specimens. A breakthrough has been recently made toward understanding the etiology of ovarian GrCTs. Forkhead box L2 (FOXL2) is an ovaryexpressed gene essential for granulosa cell differentiation (Uhlenhaut et al., 2009) . It was discovered that the vast majority of adult type GrCTs in the ovary bear a missense mutation of FOXL2 (402 C→G; C134W) (Shah et al., 2009) . This mutation was also found in testicular GrCTs of males (Lima et al., 2012) , indicating the importance of FOXL2 mutation in the pathogenesis of GrCTs. However, how FOXL2 mutation activates tumorigenic cascade within granulosa cells is not known. Interestingly, experimental evidence supports a potential link between FOXL2 mutation and alteration of TGFB/activin signaling in GrCT development (Rosario et al., 2012; Cheng et al., 2014; Fang et al., 2016) . TGFB superfamily signaling is involved in the development of GrCTs (Middlebrook et al., 2009) . In an earlier study, we created a mouse model harboring constitutively active TGFB receptor 1 (TGFBR1) using anti-Mullerian hormone receptor type 2 (Amhr2)-Cre recombinase . Amhr2-Cre has been widely used to target genes in granulosa and theca cells of the ovary, myometrial and endometrial cells of the uterus (Li et al., , 2011 Ren et al., 2009; Wang et al., 2016) , and Sertoli cells and Leydig cells of the testis (Boyer et al., 2008) . Expression of Amhr2-Cre has been detected as early as 11.5 days post-coitum in the urogenital ridges of both males and females, and the Cre activity is present in the somatic cells of gonads and the mesenchyme of Mullerian ducts (Jamin et al., 2002) . To generate constitutively active TGFBR1, three missense mutations in the GS domain were made to activate the TGFBR1 kinase (T204D) and block the binding of the TGFBR1 inhibitor, FKBP12 (L193A/P194A) (Bartholin et al., 2008) . A LoxP-flanked stop sequence was engineered to direct the expression of constitutively active TGFBR1 to Cre-expressing cells/tissues. Overactivation of TGFBR1 in the ovary results in formation of ovarian tumors reminiscent of GrCTs . Here, we report that male mice with constitutive activation of TGFBR1 in the testes developed tumors resembling testicular GrCTs. This study developed a useful mouse model for testicular GrCTs.
Materials and Methods

Ethics statement
Animal use protocol for this study was approved by the Institutional Animal Care and Use Committee (IACUC) at Texas A&M University. All animals were handled in accordance with the guidelines by the IACUC of Texas A&M University.
Animals and tissue collection
Mice harboring a latent constitutively active TGFBR1 (TGFBR1 CA ) were created as described (Bartholin et al., 2008; Vincent et al., 2010) . The TGFBR1
CA flox/flox mice were crossed to Amhr2-Cre line (Jamin et al., 2002) to generate mice containing constitutively active TGFBR1 in the testes (TGFBR1 CA flox/+ ; Amhr2-Cre). These mice were termed TGFBR1-CA Acre .
Mice were on a mixed C57BL/6/129 background and maintained by controlled light/dark cycles with free access to food and water. Testis samples were collected from both control and TGFBR1-CA Acre males during developmental stages for histological and immunohistochemical analyses described below. Genotyping was performed using DNA extracted from mouse tails described previously (Bartholin et al., 2008; Gao et al., 2016) . PCR products were separated on 1% agarose gels containing ethidium bromide and digital images captured using a VWR Gel Imager.
Histology
Testis samples from control and experimental mice were fixed in 10% (v/v) neutral buffered formalin and/or Bouin's solution for histology and immunostaining. Tissue samples were processed and embedded using the histology core lab in the Department of Veterinary Integrative Biosciences at Texas A&M University. Haematoxylin and eosin (H and E) staining was performed using standard procedures.
Immunohistochemistry and immunofluorescence
Immunohistochemistry (IHC) and Immunofluorescence (IF) were performed as described elsewhere (Gao et al., 2015 . In brief, paraffin sections (5 μm) were deparaffinized in xylene, rehydrated in graded alcohol and boiled in 10 mM citrate buffer (pH 6.0) for 20 min to retrieve the antigen. After antigen retrieval, sections were treated with 0.3% H 2 O 2 for 30 min to quench endogenous peroxidase activity. This step was only needed for IHC. Then, sections were sequentially incubated with nonimmune serum (for IHC) or bovine serum albumin (for IF), primary antibodies with indicated dilutions ( 
Western blotting
Western blotting was conducted as described . Protein lysates from mouse testis tissues were prepared using radioimmunoprecipitation assay buffer containing both proteinase ( Quantification of western blotting results was performed using NIH image J (version 1.51e).
RNA preparation and reverse transcriptionreal-time PCR
RNA samples were isolated from testes of control and TGFBR1-CA Acre males using RNeasy Mini Kit (Qiagen, USA) based on instructions provided by the supplier. Potential genomic DNA contamination was eliminated by inclusion of an additional on-column DNase digestion step.
Concentrations of the RNA preparations were determined by using NanoDrop Spectrophotometer ND 1000 (NanoDrop Technologies, USA). RNA samples were then subjected to reverse transcription for cDNA synthesis (Gao et al., 2014) . Real-time PCR was performed using a CFX Connect Real-time PCR Detection System (Bio-Rad Laboratories; USA). The 10 μl reaction system contained iTaq Universal SYBR Green Supermix (Bio-Rad Laboratories; USA) or TaqMan Universal PCR Master Mix, cDNA and oligo primers or the Taqman probe. Assays were performed in duplicates for each sample and a mean cycle threshold (CT) value was calculated. Primers for Ccnd2 were 5′-GAGTGGGAACTGGTAGTGTTG-3′ (forward) and 5′-CGCACAGAGCGATGAAGGT-3′ (reverse) (PrimerBank ID 6 753 310a1) (Spandidos et al., 2008) . Gja1 expression was analyzed using Taqman probe (Assay ID: Mm01179639_s1). Ribosomal protein L19 (Rpl19) was used as an internal control to normalize gene expression (Livak and Schmittgen, 2001; Gao et al., 2014) . A Taqman probe for Rpl19 (Assay ID: Mm02601633_g1) was included in Taqman gene expression assays.
Statistical analysis
Comparisons of means between two groups were made using unpaired two-tail t-test. Data are presented as mean ± SEM. Statistical significance was defined when P value is <0.05 and marked as * P < 0.05, ** P < 0.01 and ***P < 0.001.
Results
Generation of mice with constitutively active TGFBR1 in testes using Amhr2-Cre recombinase
We previously reported that constitutive activation of TGFBR1 in the ovary using Amhr2-Cre recombinase leads to the development of ovarian sex cord-stromal tumors reminiscent of GrCTs . Because Amhr2-Cre is also expressed in Sertoli and Leydig cells of the testis (Boyer et al., 2008) , we examined potential effects of overactivation of TGFBR1 on the development and function of the testis by generating a mouse model harboring constitutively active TGFBR1 in the testis (Fig. 1A ). As expected, TGFBR1 CA proteins were readily detectable in the testes of TGFBR1-CA Acre males but not controls by western blotting using anti-hemagglutinin (HA) antibody (Fig. 1B) . These findings support that Amhr2-Cre drives the expression of TGFBR1 CA in mouse testes. TGFBR1 phosphorylates and activates SMAD2/3 signal transducers. To verify activation of TGFB signaling in TGFBR1-CA Acre testes, we performed western blotting to determine the levels of phospho-SMAD2/3 in the testes of TGFBR1-CA Acre males. Results
showed that the levels of both phospho-SMAD2 and phospho-SMAD3 were elevated in TGFBR1-CA Acre testes compared with controls ( Fig. 1B) . SMAD2, SMAD3 and beta-actin (ACTB) were included as controls (Fig. 1B ).
TGFBR1-CA Acre males develop testicular tumors with impaired spermatogenesis
Sterility was observed in TGFBR1-CA Acre male mice when they were used as breeders. To determine the cause of sterility, we performed macroscopic and histological analyses of testes and epididymides of control and TGFBR1-CA Acre males. Gross testicular tumors with hemorrhagic foci were observed in TGFBR1-CA Acre mice around 2 months of age with full penetrance (Fig. 2A) . In contrast, no tumors were observed in control mice ( Fig. 2A) . Testicular tumors progressed with age ( Fig. 2B ). Histological analysis of 2-month-old testes showed that while control mice had organized seminiferous tubules ( , phospho-SMAD2 and phospho-SMAD3 in the testes of control and TGFBR1-CA male mice at the age of 2 weeks. Each lane represents an independent testis sample. n = 4. SMAD2, SMAD3 and ACTB were included as controls.
were displaced by circumscribed tumor nests containing poorly differentiated cells or granulosa-like cells (Fig. 2D and F and Supplementary Fig. 1B and D) . Remnant seminiferous tubules lacking mature germ cells which were observed in control testes could be found near the edge of TGFBR1-CA Acre testes ( Supplementary Fig. 1A-D) . Both histological results and IF analyses using antibody directed to smooth muscle actin alpha (ACTA2) to mark the structure of epididymis demonstrated lack of sperm in the epididymis of TGFBR1-CA Acre males ( Fig. 2H and J) , and this was in sharp contrast to wild type controls where abundant sperm/sperm DNA could be found within the epididymis ( Fig. 2G and I) . Analysis of testes from 5-6-month-old TGFBR1-CA Acre males demonstrated development of more hemorrhagic tumors (Supplementary Fig. 1F and H), in contrast to control testes containing morphologically normal seminiferous tubules (Supplementary Fig. 1E and G). Thus, testicular tumors resulting from constitutive activation of TGFBR1 are detrimental to normal testis development and spermatogenesis.
Disruption of testis development in postnatal TGFBR1-CA Acre males
To define a timeline of testicular tumor development in the TGFBR1-CA Acre males, we first performed histological analyses using testes from both control and TGFBR1-CA Acre mice at the age of 1 week, 2 weeks and 1 month. No histological difference was observed in the testes of TGFBR1-CA Acre mice versus controls at 1 week of age (Supplementary Fig. 2A and B) . Although the basic histological structure of seminiferous tubules appeared to be maintained in the TGFBR1-CA Acre testes by 2 weeks of age (Supplementary Fig. 2C and D), microscopic lesions were evident within the testes of TGFBR1-CA Acre mice at 1 month of age (Supplementary Fig. 2F and H).
Compared with control testes consisting of highly organized seminiferous tubules (Supplementary Fig. 2E and G), loss of germ cells occurred within the seminiferous tubules of TGFBR1-CA Acre testes (Supplementary Fig. 2F and H). Enrichment of Sertoli-like cells was observed in abnormal tubules of TGFBR1-CA Acre mice ( Supplementary Fig. 2F ). Tumor nodules were readily discernible in TGFBR1-CA Acre testes at this stage ( Supplementary Fig. 2H ). The histological findings were confirmed by immunohistochemical staining of Y box protein 2 (YBX2, also known as MSY2), a marker for germ cells (Gu et al., 1998) and Ki67 (a marker for cell proliferation). YBX2 was abundantly expressed in germ cells within seminiferous tubules in control testes (Fig. 3A) . However, loss of YBX2-positive cells was pronounced in the seminiferous tubules of TGFBR1-CA Acre males at 1 month of age (Fig. 3B) . The adverse effect of constitutive activation of TGFBR1 on germ cell production could be observed at 2 weeks (Supplementary Fig. 2I and J) . Moreover, the neoplastic tumor foci contained proliferative cells, evidenced by intense staining of Ki67 versus controls ( Fig. 3C and D) . Enhanced cell proliferation of TGFBR1-CA Acre testes was further supported by upregulation of cyclin D2 (CCND2) protein and transcripts ( Fig. 3E and F) . Interestingly, double IF demonstrated colocalization of Ki67 and SOX9, a Sertoli cell marker, in 1-month-old TGFBR1-CA Acre testes (yellow/orange labeling; Fig. 3J-L) , in sharp contrast to control testes where SOX9 and Ki67 signals did not overlap (Fig. 3G-I) . A similar result supporting Sertoli cell proliferation in TGFBR1-CA Acre testes was found using 2-week-old mice ( Supplementary Fig. 3 ). Since Sertoli cells stop proliferating around 2 weeks after birth in mice (Vergouwen et al., 1991), our results indicate that sustained activation of TGFBR1 extends the proliferation of Sertoli cells. As gap junction protein alpha 1 (GJA1), also known as Connexin 43, is implicated in Sertoli cell development and conditional loss of GJA1 in Sertoli cells impedes the differentiation but extends the proliferation of Sertoli cells (Sridharan et al., 2007) , we examined the expression of GJA1 in TGFBR1-CA Acre testes to determine whether altered Sertoli cell proliferation was associated with reduced expression of GJA1. A significant change of Gja1 mRNA abundance was not found in the testes of TGFBR1-CA Acre mice at 2 weeks of age ( Supplementary Fig. 4A ), although localization of GJA1 proteins appeared to be increased in cells within the basal region of the seminiferous tubules ( Supplementary Fig. 4B and C). At 1 month of age, mRNA levels of Gja1 were markedly elevated and abundant immunoreactive signals of GJA1 detected in TGFBR1-CA Acre testes compared with controls ( Supplementary Fig. 4D-F) .
These results are in concordance with reports that TGFB upregulates GJA1 expression in human granulosa cells and trophoblast cells (Chen et al., 2015; Cheng et al., 2015) and suggest that altered Sertoli cell proliferation in TGFBR1-CA Acre mice is not a result of deficient production of GJA1. To further probe the cellular and molecular alterations resulting from constitutive activation of TGFBR1 in the testis, we performed IF using antibodies directed to SOX9 and ACTA2 (Fig. 4) . Results showed that ACTA2-labeled seminiferous tubules (green) in the testes of TGFBR1-CA Acre were structurally comparable to those of controls at 2 weeks of age, except for disorganized arrangement of Sertoli cells labeled by SOX9 (red; Fig. 4A-F ). In accordance with the histological observation of enrichment of Sertoli-like cells in the dysplastic seminiferous tubules in 1-month- old TGFBR1-CA Acre males ( Supplementary Fig. 2F ), markedly disorganized arrangement of SOX9-positive cells was found within these abnormal tubules (Fig. 4G-I ). This result also provided indirect support for the aforementioned observation of germ cell depletion in TGFBR1-CA Acre testes. In addition, SOX9 staining was low to undetectable in tumor foci/ nodules, in contrast to the strong immunoreactive signals of SOX9 observed in adjacent dysplastic tubules (Fig. 4J-L) . Therefore, these studies suggest potential loss of SOX9 expression in tubule-like structures/ neoplastic nodules during tumor development and progression.
Testicular tumors in TGFBR1-CA Acre males express markers of GrCTs
As testicular tumors in TGFBR1-CA Acre mice histologically resembled ovarian GrCTs, we examined the expression of several granulosa cell markers that are expressed by GrCTs including inhibin alpha (INHA), forkhead box O1 (FOXO1) and FOXL2 within the testes of TGFBR1-CA Acre males. IHC revealed that testicular tumor nodules in 2-monthold TGFBR1-CA Acre mice were positively stained for INHA ( Fig. 5B and C), FOXO1 ( Fig. 5E and F) and FOXL2 ( Fig. 5H and I) compared with controls (Fig. 5A, D and G) . Notably, FOXL2 is a granulosa cell lineage marker expressed in the ovary but not the testis (Wilhelm et al., 2009) . To determine the temporal expression of FOXL2 in TGFBR1-CA Acre testes, we examined mice at 1 month of age, when microscopic tumor foci were detectable ( Supplementary Fig. 2H ). Interestingly, FOXL2 staining was found in some abnormal seminiferous tubules or tumor nodules in TGFBR1-CA Acre testes (Fig. 5K and L) , in stark contrast to control testes which did not express FOXL2 (Fig. 5J ). Representative negative controls using isotype-matched IgGs are depicted in Supplementary Fig. 5 . Supporting the IHC findings, protein bands of FOXL2 were only detected in the testes of TGFBR1-CA Acre mice but not those of controls by western blotting (Fig. 5M ).
These results indicate that constitutive activation of TGFBR1 in the testis may alter Sertoli cell fate. It has been well established that doublesex and mab-3 related transcription factor 1 (DMRT1) maintains testis identity; and Sertoli cells could be reprogramed to granulosa cells in the testis upon deletion of Dmrt1 due to activation of Foxl2 and other female-promoting genes (Raymond et al., 2000; Matson et al., 2011) . In postnatal mouse testis, DMRT1 is expressed in mitotic spermatogonia and Sertoli cells (Matson et al., 2011) . To explore whether the aberrant expression of FOXL2 in our mouse model was associated with loss of DMRT1 expression, we performed immunohistochemical analysis of DMRT1 and IF of DMRT1 and FOXL2 using testes from control and TGFBR1-CA Acre mice.
DMRT1 was expressed in the testes from both control and TGFBR1-CA Acre mice at 2 weeks of age ( Supplementary Fig. 6 ). At 1 month of age, expression of FOXL2 in TGFBR1-CA Acre testes could be detected in a subset of DMRT1-negative cells within disorganized tubules (Fig. 6B , E, H and K) or in majority of cells within some tumor nodules containing scattered DMRT1-expressing cells (Fig. 6C, F, I and L). In tumor foci where FOXL2-positive cells prevailed, no DMRT1 was detected (data not shown). In contrast, immunoreactive signals for FOXL2 were not detected in control testes (Fig. 6A , D, G and J). These results provide circumstantial evidence supporting a potential link between loss of DMRT1 and altered Sertoli cell fate in TGFBR1-CA Acre testes.
As mentioned above, tumor nodules in TGFBR1-CA Acre testes expressed minimal SOX9. However, loss of SOX9 may also occur during the development of Sertoli cell tumors (Chang et al., 2009) . To further determine whether tumor cells expressed other Sertoli cell markers, we examined Wilms tumor 1 (WT1), a Sertoli cell expressed protein that is detectable in mouse Sertoli cell tumors (Chang et al., 2009) . The results showed that WT1 was expressed in Sertoli cells of control testes and abnormal seminiferous tubules (Fig. 7A-D) , but not the parenchyma of the tumors at 2 months of age ( Fig. 7C and D) . In addition, to elucidate whether the tumors expressed Leydig cell markers, we analyzed the expression of CYP17A1 (Liu et al., 2016) . Results showed that CYP17A1 was localized to Leydig cells in control testes (Fig. 7E and F) . However, only scattered CYP17A1-postive cells were observed in testicular tumors of TGFBR1-CA Acre mice ( Fig. 7G and H) , supporting the finding that tumors were not derived from Leydig cells. These results collectively indicate that constitutive activation of TGFBR1 in the testis leads to development of sex cord-stromal tumors resembling GrCTs.
WNT/CTNNB1 signaling is active in GrCTs resulting from TGFBR1 overactivation
Misregulation of WNT/beta-catenin (CTNNB1) signaling is implicated in tumorigenesis of GrCTs in multiple species including humans, horses Herein, we demonstrated that the levels of CTNNB1 were increased in testicular tumor tissues of TGFBR1-CA Acre mice at 1 month of age compared with controls ( Fig. 8A and B) . IHC confirmed the results of western blotting by revealing extensive immunoreactive signals of CTNNB1 in testicular tumors of TGFBR1-CA Acre males versus controls ( Fig. 8C-E) . Moreover, variable degrees of nuclear/cytoplasmic staining of CTNNB1 were observed in testicular tumor tissues (Fig. 8E) . These results suggest that dysregulation of WNT/CTNNB1 signaling is potentially linked to GrCT development in TGFBR1-CA Acre mice.
Discussion
GrCTs may arise from the testis with low incidence (JimenezQuintero et al., 1993; Wang et al., 2002) . The adult type GrCTs of the testis are extremely rare and occur after puberty, whereas the juvenile type GrCTs account for approximately 1-4% of total prepubertal testicular tumors and the majority of them develop within the first 6 months Shukla et al., 2004; Dudani et al., 2008) . While adult GrCTs are associated with somatic mutation (Lima et al., 2012) , the juvenile type GrCTs may be associated with chromosomal abnormalities and gonadal dysgenesis Kos et al., 2005) . Animal models are useful to investigate the pathogenesis of this disease. Several mouse models are available for sex cordstromal tumors, including but not limited to, mice with targeted deletion of Inha (Matzuk et al., 1992) , Smad1/5 and BMP type 1 receptors (Edson et al., 2010) , mice with overexpression of R-spondin 1 (Rspo1) (De Cian et al., 2017) , mice containing KRAS activation and dominant-stable CTNNB1 (Richards et al., 2012) , and mice with dominant-stable CTNNB1 or both dominant-stable CTNNB1 and Pten inactivation (Boerboom et al., 2005; Boyer et al., 2009; Richards et al., 2012) . Although it is challenging to faithfully model human GrCTs, mouse models have helped to gain significant insights into the pathobiology and signaling cascades of GrCT development. We previously reported that overactivation of TGFBR1 using Amhr2-Cre to target mouse granulosa cells provokes the development of ovarian GrCTs . Since Amhr2-Cre has been successfully used to conditionally target/overexpress genes in somatic cells of the gonad in both sexes (Jamin et al., 2002; Jeyasuria et al., 2004; Boyer et al., 2008 Boyer et al., , 2009 Pangas et al., 2008; Papaioannou et al., 2009; Tanwar et al., 2010; Kyronlahti et al., 2011) , we determined the phenotypic consequence of constitutive activation of TGFBR1 using Amhr2-Cre in the testis. Formation of microscopic abnormalities observed in testicular tubules of TGFBR1-CA Acre males before puberty suggests balanced TGFB signaling is essential for testis development. Development of testicular tumors was accompanied by increased cell proliferation and depletion of germ cells. It was reported that TGFB superfamily signaling is active in the mouse testis, and the dosage of activin A maintains balanced numbers of Sertoli cells and germ cells (Mendis et al., 2011) . As activin and TGFB signaling shares the same downstream SMADs, SMAD2/3, it appears possible that loss of germ cells in TGFBR1-CA Acre testes may be associated with altered SMAD2/3 signaling activity.
To strengthen the conclusion that testicular tumors resembled GrCTs, we examined the spatiotemporal localization of several protein markers including SOX9, CYP17A1 and FOXL2 for the respective Sertoli cells, Leydig cells and granulosa cells. During the development of testicular GrCTs, we observed accumulation of Sertoli cells within seminiferous tubules, expression of Ki67 in Sertoli cells and reduction of SOX9 expression but gain of FOXL2 expression in tumor nodules. The origin of testicular GrCT is poorly defined. However, based on the aforementioned findings and the observation that testicular GrCTs arose within seminiferous tubules, it is tempting to postulate that Sertoli cells might transdifferentiate into granulosa tumor cells. Moreover, neither the histological feature nor the expression pattern of CYP17A1 supported that these tumors were Leydig cell tumors. Of note, the most common cell type of Leydig cell tumors is mediumsized hexagonal cell that has eosinophilic/vacuolar cytoplasm, irregular round/oval shaped nucleus and recognizable cell border (Mostofi, 1973) . It is unclear whether gain of FOXL2 expression in TGFBR1-CA Acre testes is a cause or consequence of testicular GrCT development. It has been suggested that both granulosa cells and Sertoli cells share the same progenitors (Albrecht and Eicher, 2001) , and granulosa cells can transdifferentiate into Sertoli cells in adult female mice lacking FOXL2 (Uhlenhaut et al., 2009) . Conversely, it is logic to speculate that the fate of Sertoli cells may be altered to resemble granulosa cells when FOXL2 is misregulated. Indeed, Sertoli cells could be reprogramed to granulosa cells upon conditional loss of DMRT1 due to activation of Foxl2 and other female-promoting genes (Matson et al., 2011) . Another study showed that constitutive activation of CTNNB1 in Sertoli cells promotes FOXL2 expression ectopically in the testis, resulting in the transformation of Sertoli cells into granulosa-like cells (Li et al., 2017) . Moreover, upregulation of FOXL2 in testicular GrCTs was found in an independent mouse model, where CTNNB1 and AKT signaling was genetically enhanced (Boyer et al., 2009) . Our result is also in agreement with the discovery that aberrant expression of FOXL2 links to the development of human juvenile GrCTs of the testis (Kalfa et al., 2008) . The finding of gain of FOXL2-expressing cell population but loss of cells positive for DMRT1, a key protein that maintains Sertoli cell identify (Raymond et al., 2000; Matson et al., 2011) in testicular tubules of TGFBR1-CA Acre males during tumor development highlights the importance of TGFB pathway in maintaining the balance of 'male-female' characteristics in the gonad. In view of the early onset of tumorigenesis, the potential of TGFBR1-CA Acre mice as a model for the juvenile GrCTs should be further explored. Our current findings support an equally important role of TGFB signaling in the development of GrCTs in both male and female gonads . Somatic mutation of FOXL2 has been identified as a hallmark of ovarian adult GrCTs (Shah et al., 2009) . FOXL2 mutation was also revealed in testicular GrCTs (Lima et al., 2012) . Moreover, activation of TGFB signaling appears to be associated with GrCT development Middlebrook et al., 2009; Edson et al., 2010; Liu et al., 2015; Kim et al., 2016) . Interestingly, FOXL2 mutation may impact activin/TGFB signaling (Rosario et al., 2012; Cheng et al., 2014; Fang et al., 2016) . Previous studies indicated that unopposed activin signaling resulting from loss of inhibin promotes testicular tumor development partially through SMAD3, a critical regulator of sex cord-stromal tumor development (Li et al., 2007) . Thus, SMAD mediated signaling likely contributes to testicular tumor Three mice per group were examined. Scale bar is representatively shown in (C), and equals 10 μm (E) and 50 μm (C and D). development in our model system, as is supported by increased phospho-SMAD2/3 levels in the testes of TGFBR1-CA Acre males.
TGFB signaling is complex and known to interact with other pathways. WNT pathway plays fundamental roles in normal cell functions and the development of multiple types of cancers (Giles et al., 2003) . Activation of the WNT/CTNNB1 pathway is involved in the pathogenesis of GrCTs; mice expressing a dominant-stable CTNNB1 mutant in ovarian granulosa cells develop GrCTs (Boerboom et al., 2005) . Simultaneous dysregulation of CTNNB1 and phosphatidylinositol 3-kinase (PI3K)/AKT pathways causes testicular GrCT formation (Boyer et al., 2009) . Increased expression of phospho-AKT was found in both ovarian tumors and testicular tumors (unpublished observation) from TGFBR1-CA Acre mice. Moreover, the R-Spondin family proteins activate WNT signaling pathway (Kim et al., 2008) . Recent studies discovered that amplification of RSPO1 signaling leads to GrCT formation through altering the fate and properties of granulosa cells (De Cian et al., 2017) . These studies collectively indicate that enhanced WNT signaling promotes GrCT development. Supporting interactions between TGFB and WNT signaling (Akhmetshina et al., 2012) , we demonstrated that CTNNB1 expression was upregulated in testicular tumors. Moreover, WNT signaling appears to be active in gonadal tumors resulting from constitutive activation of TGFBR1. Of note, CTNNB1 signaling is suppressed during normal testis development, and WT1 negatively regulates CTNNB1 signaling (Chang et al., 2008) . Thus, lack of WT1 in tumor nodules of TGFBR1-CA Acre testes may facilitate the expression of CTNNB1.
While our studies uncovered a role of TGFBR1 activation in GrCT development, a potential regulatory mechanism of SMAD2/3-CTNNB1 activation in the pathogenesis of human GrCTs warrants further investigation. Illuminating the signaling network that underpins GrCT development will provide opportunities for designing new therapeutic interventions.
In summary, the current study created a new mouse model resembling testicular GrCTs. This mouse model may prove to be a useful addition to the mouse genetics toolkit for testicular GrCT research.
Supplementary data
Supplementary data are available at Molecular Human Reproduction Online.
